Rossano discussed unmet needs for patients with Danon disease and the potential of investigational gene therapy RP-A501.
Joseph Rossano, MD, MS, FAAP, FACC
Advertisement
Articles by Joseph Rossano, MD, MS, FAAP, FACC
Advertisement
Latest Updated Articles
Joseph Rossano, MD, on the Potential of Gene Therapy in Danon DiseasePublished: October 25th 2022 | Updated:
Advertisement
Advertisement
Trending on CGTlive®
1
CARsgen’s CAR-T Satri-Cel Significantly Reduces CA19-9 Levels in Patients With Pancreatic Ductal Adenocarcinoma
2
Around the Helix: Cell and Gene Therapy Company Updates – October 22, 2025
3
AskBio’s Heart Failure Gene Therapy AB-1002 Shows Ability to Improve NYHA Class in Phase 1 Trial
4
